Modest supplemental oxygen worsens lung injury in a murine model of sepsis
适度补充氧气会加重脓毒症小鼠模型的肺损伤
基本信息
- 批准号:7544295
- 负责人:
- 金额:$ 5.09万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2008
- 资助国家:美国
- 起止时间:2008-08-01 至 2009-06-30
- 项目状态:已结题
- 来源:
- 关键词:AcetylcysteineAcuteAcute Lung InjuryAdult Respiratory Distress SyndromeAlveolarAlveolar CellAlveolar MacrophagesAmplifiersAnimal ModelAntioxidantsApoptosisAttenuatedAutomobile DrivingBiological AssayBody Weight decreasedCell CountCellsCessation of lifeClinicalCountDataDendritic CellsDevelopmentDiseaseDoseEnvironmentEnzymesEpithelialExposure toGenerationsGoalsHealthcare SystemsHistologicHistologyHospitalizationHourHumanIn VitroIncubatedInflammatoryInjuryLigationLipopolysaccharidesLuminolLungMeasuresMediator of activation proteinModelingMorbidity - disease rateMusNewborn Respiratory Distress SyndromeOutcomeOxidative StressOxygenPathologicPathway interactionsPatternProductionProteinsPublic HealthPuncture procedureRangeReactive Oxygen SpeciesReportingRespiratory MechanicsRisk FactorsRoleSepsisSeveritiesSourceTimeToxic effectVariantWeightWorkantioxidant therapyclinically relevantcytokinedaydichlorofluorescinexperienceextracellularimprovedin vivoinsightinterstitialintraperitoneallung injurymacrophagemortalitymouse modelneutrophilresearch studywet lung
项目摘要
DESCRIPTION (provided by applicant): Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are associated with high levels of morbidity and mortality, imposing a substantial burden on the health care system. Sepsis is a frequent cause of ALI making the study of sepsis-induced lung injury crucial. Using systemic lipopolysaccharide (LPS) we observed predominantly interstitial lung injury with a paucity of alveolar neutrophils and damage, dramatically different from the prominent alveolar injury and neutrophil influx seen with direct lung injury. Along the way to understanding the difference between direct and indirect injury in mice, we postulated that 50% oxygen would augment lung injury in mice after systemic insult compared to LPS or 50% oxygen alone. Our injury model consists of LPS followed 12 hrs later by exposure to 50% or 21% oxygen for 60 hrs. At day 3, mice exposed to LPS plus oxygen showed a synergistically increase lung injury, with a prominent alveolar component, compare to other groups. We hypothesize that the addition of 50% oxygen to LPS increases oxidative stress and inflammatory cytokine production, thereby augmenting lung injury, and that injury can be mitigated with antioxidant therapy. We plan to examine aspects of this hypothesis with following 2 aims: 1. To examine potential mechanisms driving the augmentation of lung injury by combined exposure to LPS and supplemental oxygen. Mice exposed to LPS, 50% oxygen, or LPS plus oxygen, will be assessed for mortality, weight loss; BAL cell counts, differentials, total protein, wet lung weight; and histology. In addition, we will measure: intracellular and extracellular ROS generation; lung anti-oxidant enzyme levels; BAL/Lung cytokines; and alveolar cell apoptosis at defined intervals. In vitro, we will incubate naive alveolar macrophages (AMs) and dendritic cells (DCs) with LPS, 50% oxygen, or in combination, and measure ROS production and key inflammatory mediators previously identified. 2. To determine if NAc therapy concurrent with supplemental oxygen abrogates lung injury, and examine potential mechanisms of that effect. NAc or control will be given to groups as in Aim 1, and the effect on injury patterns will be assessed. In addition, we will examine cytokine and anti-oxidant potential pathways indicated by Aim 1 findings, as well as time- and cell-specific ROS and apoptosis activity. Public Health Relevance: Significant injury to the lungs requiring hospitalization and death can occur from systemic illness. We will examine the role of moderate oxygen as a potential amplifier of that injury in an animal model. This work has the potential to improve human outcomes and decrease burden on the health care system from this devastating illness.
描述(由申请人提供):急性肺损伤(ALI)和急性呼吸窘迫综合征(ARDS)与高发病率和死亡率相关,给医疗保健系统带来沉重负担。脓毒症是 ALI 的常见原因,因此脓毒症引起的肺损伤的研究至关重要。使用全身脂多糖(LPS),我们观察到主要是间质性肺损伤,伴有少量肺泡中性粒细胞和损伤,这与直接肺损伤中观察到的显着肺泡损伤和中性粒细胞流入有显着不同。在了解小鼠直接损伤和间接损伤之间的差异的过程中,我们假设与仅使用 LPS 或 50% 氧气相比,50% 氧气会加重全身损伤后小鼠的肺损伤。我们的损伤模型包括 LPS,12 小时后暴露于 50% 或 21% 氧气 60 小时。在第 3 天,与其他组相比,暴露于 LPS 加氧气的小鼠显示出协同增加的肺损伤,其中肺泡成分明显。我们假设向 LPS 中添加 50% 的氧气会增加氧化应激和炎症细胞因子的产生,从而加剧肺损伤,并且可以通过抗氧化治疗减轻损伤。我们计划通过以下两个目标来检验这一假设的各个方面: 1.检验联合暴露于 LPS 和补充氧气导致肺损伤加剧的潜在机制。将评估暴露于 LPS、50% 氧气或 LPS 加氧气的小鼠的死亡率、体重减轻; BAL 细胞计数、差异、总蛋白、肺湿重;和组织学。此外,我们还将测量:细胞内和细胞外 ROS 的生成;肺抗氧化酶水平; BAL/肺细胞因子;和肺泡细胞凋亡在规定的时间间隔。在体外,我们将用 LPS、50% 氧气或两者的组合孵育幼稚肺泡巨噬细胞 (AM) 和树突状细胞 (DC),并测量 ROS 产生和先前确定的关键炎症介质。 2. 确定 NAc 治疗与补充氧气同时进行是否可以消除肺损伤,并检查该作用的潜在机制。将按照目标 1 向各组提供 NAc 或对照,并评估对损伤模式的影响。此外,我们将检查 Aim 1 研究结果表明的细胞因子和抗氧化潜在途径,以及时间和细胞特异性 ROS 和细胞凋亡活性。公共卫生相关性:全身性疾病可能会导致严重的肺部损伤,需要住院治疗甚至死亡。我们将在动物模型中研究适度的氧气作为潜在的损伤放大器的作用。这项工作有可能改善人类的健康状况,并减轻这种毁灭性疾病给医疗保健系统带来的负担。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Neil Raj Aggarwal其他文献
Neil Raj Aggarwal的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Neil Raj Aggarwal', 18)}}的其他基金
相似海外基金
Combinatorial cytokine-coated macrophages for targeted immunomodulation in acute lung injury
组合细胞因子包被的巨噬细胞用于急性肺损伤的靶向免疫调节
- 批准号:
10648387 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
Inducible HMGB1 antagonist for viral-induced acute lung injury.
诱导型 HMGB1 拮抗剂,用于治疗病毒引起的急性肺损伤。
- 批准号:
10591804 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
MAP2K1 AND MAP2K2 IN ACUTE LUNG INJURY AND RESOLUTION
MAP2K1 和 MAP2K2 在急性肺损伤中的作用及缓解
- 批准号:
10741574 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
Lung epithelial cell-derived C3 in acute lung injury
肺上皮细胞衍生的 C3 在急性肺损伤中的作用
- 批准号:
10720687 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
Examining the role of TRMT1 and tRNA methylation in acute lung injury and ARDS
检查 TRMT1 和 tRNA 甲基化在急性肺损伤和 ARDS 中的作用
- 批准号:
10719249 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
Development of a new treatment for COVID-19-related acute lung injury targeting the microbiota-derived peptide corisin
针对微生物群衍生肽 corisin 开发治疗 COVID-19 相关急性肺损伤的新疗法
- 批准号:
23K07651 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Probing immunovascular mechanobiology in pneumonia-associated acute lung injury at the single capillary level
在单毛细血管水平探讨肺炎相关急性肺损伤的免疫血管力学生物学
- 批准号:
10679944 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
The amyloid precursor protein protects against acute lung injury
淀粉样前体蛋白可预防急性肺损伤
- 批准号:
10575258 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
Role of macrophages and miRNA in regulating lung macrophage polarization and lung pathogenesis during respiratory virus-induced acute lung injury in normal and diabetic Syrian hamsters.
正常和糖尿病叙利亚仓鼠呼吸道病毒引起的急性肺损伤期间巨噬细胞和 miRNA 在调节肺巨噬细胞极化和肺部发病机制中的作用。
- 批准号:
10701207 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:
Roles of N-glycans on neutrophil beta2 integrins in progression of acute lung injury
N-聚糖对中性粒细胞β2整合素在急性肺损伤进展中的作用
- 批准号:
10837431 - 财政年份:2023
- 资助金额:
$ 5.09万 - 项目类别:














{{item.name}}会员




